These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9350094)

  • 41. Lone parent families are an independent risk factor for lower rates of childhood immunisation in London.
    Sharland M; Atkinson P; Maguire H; Begg N
    Commun Dis Rep CDR Rev; 1997 Oct; 7(11):R169-72. PubMed ID: 9350095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil.
    Barreto ML; Cunha SS; Pereira SM; Genser B; Hijjar MA; Yury Ichihara M; de Brito SC; Dourado I; Cruz A; Santa'Ana C; Rodrigues LC
    Int J Tuberc Lung Dis; 2005 Oct; 9(10):1171-3. PubMed ID: 16229231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evolution of the vaccination timetable in Morocco].
    Bouazzaoui NL
    Bull Acad Natl Med; 2006; 190(4-5):1017-32; discussion 1032-3. PubMed ID: 17195625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective neonatal BCG immunisation in a multiethnic community: poor uptake among white British infants.
    Menon L; Srinivasan R; Alfaham M
    Commun Dis Public Health; 2004 Dec; 7(4):388. PubMed ID: 15779807
    [No Abstract]   [Full Text] [Related]  

  • 45. Efficacy of the BCG revaccination programme in Hong Kong.
    Green RA
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1161-2. PubMed ID: 11769776
    [No Abstract]   [Full Text] [Related]  

  • 46. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survey of BCG vaccination policy in Europe: 1994-96.
    Trnka L; Dankova D; Zitova J; Cimprichova L; Migliori GB; Clancy L; Zellweger JP
    Bull World Health Organ; 1998; 76(1):85-91. PubMed ID: 9615500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of Bacillus Calmette-Guèrin vaccination at birth and 2 months old age on the peripheral blood T-cell subpopulations [gamma/delta and alpha-beta T cell].
    Taştan Y; Arvas A; Demir G; Alikaşifoğlu M; Gür E; Kiray E
    Pediatr Allergy Immunol; 2005 Dec; 16(8):624-9. PubMed ID: 16343082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BCG vaccination and WHO's global strategy for tuberculosis control 1948-1983.
    Brimnes N
    Soc Sci Med; 2008 Sep; 67(5):863-73. PubMed ID: 18573583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [BCG vaccine coverage in private medical practice: First data in children below two years old, seven months after the end of compulsory vaccination in France].
    Guthmann JP; de La Rocque F; Boucherat M; van Cauteren D; Fonteneau L; Lécuyer A; Cohen R; Lévy-Bruhl D
    Arch Pediatr; 2009 May; 16(5):489-95. PubMed ID: 19304464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vaccine prophylaxis of tuberculosis: implication and problems].
    Aksenova VA; Levi DT; Fonina EV; Vundtsettel' NN
    Probl Tuberk Bolezn Legk; 2009; (1):10-6. PubMed ID: 19253677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving the coverage of neonatal BCG vaccination.
    Chappel D; Fernandes V
    J Public Health Med; 1996 Sep; 18(3):308-12. PubMed ID: 8887842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccines for other neonatal infections: neonatal BCG vaccination against tuberculosis.
    Britton WJ
    Expert Rev Vaccines; 2004 Aug; 3(4):365-9. PubMed ID: 15270636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban, South Africa.
    Jeena PM; Chhagan MK; Topley J; Coovadia HM
    Bull World Health Organ; 2001; 79(4):337-43. PubMed ID: 11357213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. National tuberculosis programme review: experience over the period 1990-95.
    Pio A; Luelmo F; Kumaresan J; Spinaci S
    Bull World Health Organ; 1997; 75(6):569-81. PubMed ID: 9509630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethnic differences in selective neonatal BCG immunisation: white British children miss out.
    Srinivasan R; Menon L; Stevens P; Campbell I; Alfaham M
    Thorax; 2006 Mar; 61(3):247-9. PubMed ID: 16384882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neonatal BCG: a time for change.
    Pillay T; Toldi G; Hussain A; Magwenzi MM; Satodia P; Radcliffe R
    Arch Dis Child Educ Pract Ed; 2024 Jan; 109(1):19-24. PubMed ID: 36008111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
    Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
    Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective neonatal BCG vaccination - a re-audit.
    Venkatesan P; Jayakumar S; Sharief N
    Acta Paediatr; 2007 Jan; 96(1):145-6. PubMed ID: 17187626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.